Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Beximco Pharma | BXP | London | Depository Receipt |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.00 | 2.99% | 34.50 | 12:15:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 33.50 | 33.50 | 34.50 | 33.50 |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 29/10/2024 | Final | USD | 0.03349 | 22/11/2024 | 25/11/2024 | |
| 20/10/2023 | Final | USD | 0.031746 | 10/11/2023 | 13/11/2023 | |
| 28/10/2022 | Final | USD | 0.033221 | 17/11/2022 | 18/11/2022 | 27/03/2023 |
| 21/10/2021 | Final | USD | 0.039673 | 18/11/2021 | 19/11/2021 | 15/02/2022 |
| 29/10/2020 | Final | USD | 0.017657 | 23/11/2020 | 24/11/2020 | 27/01/2021 |
| Top Posts |
|---|
Posted at 12/11/2024 10:08 by someuwin Trading restored - looks like were in the clear...12 November 2024 BEXIMCO PHARMACEUTICALS LIMITED Update on Interim Order following decision by the Supreme Court of Bangladesh Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56 The Bangladesh Supreme Court Appellate Division today allowed Beximco Pharma's appeal against the Interim Order regarding the appointment of a receiver to manage the Beximco group of companies (which included Beximco Pharma), and confirmed that its provisions will not apply to Beximco Pharma. Following this decision, the Company's temporary suspension of trading on AIM has been lifted with immediate effect. With regards to the Writ Petition, following this decision, the Bangladesh Supreme Court Appellate Division has instructed the High Court to resolve the pending case within two weeks. Further announcements will be made in due course. |
Posted at 11/11/2024 14:05 by arlington chetwynd talbott Good illustration of the political/one country risk that abounds on AIM and can bite even those rare AIM companies like BXP that are well run and have good business models. All we poor shareholders can do is wait for the smoke to clear. |
Posted at 11/11/2024 12:46 by greg the grinch hxxps://www.thedailyI am not sure that these loans extend to BXP, he knew any stuff would be looked at in the UK, and BXP is a growing business. Seems to me they relate to the larger group. The bigger Beximco group is Bangladesh based so I reckon the nonsense should be restricted to that. I note the receiver is only going to be bought in to steady the ship, BXP is doing fine. 'Md Ruhul Amin is the executive director of sustainable finance department and investment promotion and financing facility-11 project cell of the central bank.' Might come in and do a great job. |
Posted at 11/11/2024 11:26 by someuwin Further re the Temporary Suspension of TradingBeximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56 On 30 September 2024, the Company announced that a Writ Petition with the Supreme Court of Bangladesh had been brought by a Mr. Masood Sobhan, a citizen of Bangladesh and practicing lawyer of the Supreme Court of Bangladesh as the Petitioner. The Writ Petition had been filed as a Public Interest Litigation. This Writ Petition included Beximco Pharma, in addition to the Bangladesh Bank, The Bangladesh Ministry of Finance, and Salman F. Rahman as separately listed and distinct Respondents. Inter alia, the writ asked the Court to direct the Bangladesh Bank to "appoint a Receiver to manage the companies of [the] Beximco Group of Companies." Pending a hearing on this Writ Petition, the Supreme Court of Bangladesh issued an Interim Order, which inter alia directed the Bangladesh Bank to "appoint a Receiver to manage the companies of Beximco Group of companies for a period of 06 (six) months from date …". On 2 October 2024, the Company announced that at a court hearing of the Appellate Division in Bangladesh, the Judge-in Chamber passed "No Order" and referred Beximco Pharma's appeal to a full-court hearing on 28 October 2024. This was subsequently adjourned until 11 November 2024 as announced by the Company on 28 October 2024. The Company notes local press coverage in Bangladesh yesterday, 10 November 2024, that the Bangladesh Bank has appointed a receiver to Beximco Pharma in compliance with the Court's Interim Order. To confirm, Beximco Pharma has not been informed of this development in writing. Beximco Pharma's appeal was duly heard in the full-court hearing today and the Supreme Court of Bangladesh stated it will issue its decision tomorrow, 12 November 2024. The receiver's appointment to Beximco Pharma will, therefore, remain subject to the decision tomorrow. As a result of the uncertainty around the appointment of a receiver, the lack of clarity in respect of their terms of appointment and the deferral of the Court's decision until tomorrow, Beximco Pharma requested a temporary suspension of trading in the Company's shares on AIM, which occurred at 7.30am this morning. The Company's shares remain suspended from trading on AIM. Further announcements will be made in due course. |
Posted at 11/11/2024 09:30 by someuwin Receivers been called in to the parent company. Not sure what effect will be on BXP? |
Posted at 07/11/2024 07:12 by someuwin Excellent results!And dividend of 7.9% |
Posted at 29/10/2024 11:19 by arlington chetwynd talbott Whatever the divi amounts to, I will reinvest it with glee. This one is my pharma equivalent of PTAL - a decent company with country/political risk but a very healthy dividend. My gold mining equivalent was CEY, but it got nicked. |
Posted at 29/10/2024 09:17 by someuwin Yup - great results. Looks like almost 9% divi. |
Posted at 04/9/2024 10:13 by arlington chetwynd talbott Your typical AIM scam does not have a dividend history like BXP has. Or, indeed, a dividend history. |
Posted at 17/2/2023 07:24 by live ink RE: BXP dividendKurian, Vinu To: SIMON CAWKWELL cawkwell@btinternet. 16/02/23 19:38 1 Dear Mr. Cawkwell, Pardon me for the delay in the response. Please note that the DR payable date for the dividend has not yet been fixed due to the low liquidity ratio for the conversion of the local currency BDT into USD. Once all the dividend monies received by the Depositary in BDT are converted into USD, we will be able to set a DR payable date for the GDR holders. A final announcement will be issued at that time to the London Stock Exchange and all market participants confirming the DR payable date. Regards, Vinu Vinu Kurian (Pronouns: He/Him/His) Global Client Solutions | Depositary Receipts BNY Mellon 240 Greenwich Street | New York, NY 10286 E: vinu.kurian@bnymello T: +1-212-815-8365 M: +1-551-404-8570 Do not send text messages to this number From: SIMON CAWKWELL Sent: Thursday, February 16, 2023 5:29 AM To: Kurian, Vinu Subject: BXP dividend Dear Mr Kurian, I emailed you perhaps two weeks ago as to what has happened to my BXP dividend. You did not acknowledge receipt of this email. So I assumed that matters would very shortly be resolved. In the event nothing has happened. Coul Dear Mr Kurian, I emailed you perhaps two weeks ago as to what has happened to my BXP dividend. You did not acknowledge receipt of this email. So I assumed that matters would very shortly be resolved. In the event nothing has happened. Could you please urgently enquire into this material matter which concerns my family's various accounts at Redmayne Bentley. Yours sincerely, Simon Cawkwell Note to BXP holders: this is a truly extraordinary state of affairs. If I understand Mr Kurian correctly he says that the BDT rate to USD is unfavourable for BXP to convert its local currency at this time. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
